Annexon to Present at the Raymond James Human Health Innovation Conference

Rhea-AI Summary

Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company, will have its President & CEO, Douglas Love, present at the Raymond James Human Health Innovation Conference on June 23, 2021, at 1:20 pm EDT. The conference will focus on the company's pipeline of novel therapies targeting classical complement-mediated autoimmune and neurodegenerative disorders. Investors can access a live webcast under the 'Events & Presentations' section on the Investors page of www.annexonbio.com, with an archived replay available for 30 days.

SOUTH SAN FRANCISCO, Calif., June 16, 2021 (GLOBE NEWSWIRE) -- Today, Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated autoimmune and neurodegenerative disorders of the body, brain and eye, announced that Douglas Love, Esq., President & Chief Executive Officer, will present at the virtual Raymond James Human Health Innovation Conference on June 23rd, 2021 at 1:20 pm EDT.

A live webcast of the event can be accessed under the ‘Events & Presentations’ section on the Investors page at www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for 30 days following the presentation.

About Annexon, Inc.
Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is deploying a disciplined, biomarker-driven development strategy designed to improve the probability of technical success of its portfolio. For more information, visit www.annexonbio.com.

FAQ

When will Annexon present at the Raymond James Human Health Innovation Conference?

Annexon will present at the Raymond James Human Health Innovation Conference on June 23, 2021, at 1:20 pm EDT.

Who will represent Annexon at the Raymond James conference?

Douglas Love, Esq., President & CEO of Annexon, will represent the company at the conference.

Where can I watch the Annexon presentation?

The presentation can be watched live on the Investors page under 'Events & Presentations' at www.annexonbio.com.

How long will the Annexon webcast be available for replay?

The replay of the Annexon webcast will be available for 30 days following the presentation.

What is Annexon, Inc. focused on?

Annexon, Inc. is focused on developing novel therapies for classical complement-mediated autoimmune and neurodegenerative disorders.